Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Mai 2014 08:37 ET | Quelle: MELA Sciences, Inc.

MELA Sciences Predictive Probability Study Supports Increased Diagnostic Accuracy by Dermatologists for Melanoma

IRVINGTON, NY--(Marketwired - May 8, 2014) - MELA Sciences, Inc. (NASDAQ: MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
07. Mai 2014 17:23 ET | Quelle: MELA Sciences, Inc.

Melanoma Diagnostic Developer, MELA Sciences, Hosts Q1 Conference Call Tuesday, May 13th at 4:30 pm ET

IRVINGTON, NY--(Marketwired - May 7, 2014) - MELA Sciences, Inc. (NASDAQ: MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
26. Mai 2010 06:30 ET | Quelle: MELA Sciences

MELA Sciences Announces FDA Panel to Review MelaFind(R) PMA Application on August 26, 2010

IRVINGTON, NY--(Marketwire - May 26, 2010) - MELA Sciences, Inc. (NASDAQ: MELA) announced today that the company's pre-market approval (PMA) application for MelaFind® will be reviewed by...